IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions

被引:179
作者
Matsuki, T [1 ]
Horai, R [1 ]
Sudo, K [1 ]
Iwakura, Y [1 ]
机构
[1] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Toyota 1088639, Japan
关键词
IL-1-deficient mouse; IL-1 receptor antagonist-deficient mouse; obese; skinny model; energy homeostasis;
D O I
10.1084/jem.20030299
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-1 is a proinflammatory cytokine that plays important roles in inflammation. However, the role of this cytokine under physiological conditions is not known completely. In this paper, we analyzed the role of IL-1 in maintaining body weight because IL-1 receptor antagonist-deficient (IL-1Ra(-/-)) mice, in which excess IL-1 signaling may be induced, show a lean phenotype. Body fat accumulation was impaired in IL-1Ra(-/-) mice, but feeding behavior, expression of hypothalamic factors involved in feeding control, energy expenditure, and heat production were normal. When IL-1Ra(-/-) mice were treated with monosodium glutamate (MSG), which causes obesity in wild-type mice by ablating cells in the hypothalamic arcuate nucleus, they were resistant to obesity, indicating that excess IL-1 signaling antagonizes the effect of MSG-sensitive neuron deficiency. IL-1Ra(-/-) mice showed decreased weight gain when they were fed the same amount of food as wild-type mice, and lipid accumulation remained impaired even when they were fed a high-fat diet. Interestingly, serum insulin levels and lipase activity were low in IL-1Ra(-/-) mice, and the insulin levels were low in contrast to wild-type mice after MSG treatment. These observations suggest that IL-1 plays an important role in lipid metabolism by regulating insulin levels and lipase activity under physiological conditions.
引用
收藏
页码:877 / 888
页数:12
相关论文
共 65 条
  • [11] The neuropeptide Y agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice
    Broberger, C
    Johansen, J
    Johansson, C
    Schalling, M
    Hökfelt, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) : 15043 - 15048
  • [12] A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse
    Butler, AA
    Kesterson, RA
    Khong, K
    Cullen, MJ
    Pelleymounter, MA
    Dekoning, J
    Baetscher, M
    Cone, RD
    [J]. ENDOCRINOLOGY, 2000, 141 (09) : 3518 - 3521
  • [13] Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass
    Chen, AS
    Marsh, DJ
    Trumbauer, ME
    Frazier, EG
    Guan, XM
    Yu, H
    Rosenblum, CI
    Vongs, A
    Feng, Y
    Cao, LH
    Metzger, JM
    Strack, AM
    Camacho, RE
    Mellin, TN
    Nunes, CN
    Min, W
    Fisher, J
    Gopal-Truter, S
    MacIntyre, DE
    Chen, HY
    Van der Ploeg, LHT
    [J]. NATURE GENETICS, 2000, 26 (01) : 97 - 102
  • [14] Editorial: The corticotropin-releasing hormone system and feeding behavior - A complex web begins to unravel
    Cone, RD
    [J]. ENDOCRINOLOGY, 2000, 141 (08) : 2713 - 2714
  • [15] CUNNINGHAM ET, 1992, J NEUROSCI, V12, P1101
  • [16] Central and peripheral mechanisms contribute to the hypoglycemia induced by interleukin-1
    Del Rey, A
    Monge-Arditi, G
    Besedovsky, HO
    [J]. NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 : 153 - 161
  • [17] ANTIDIABETIC EFFECTS OF INTERLEUKIN-1
    DELREY, A
    BESEDOVSKY, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) : 5943 - 5947
  • [18] Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005
  • [19] Biologic basis for interleukin-1 in disease
    Dinarello, CA
    [J]. BLOOD, 1996, 87 (06) : 2095 - 2147
  • [20] DINARELLO CA, 1991, BLOOD, V77, P1627